EUR 24,50
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used. pp. 212.
Condizione: Used. pp. 212 2nd Edition.
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
EUR 24,57
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used. pp. 212.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 77,36
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 78,36
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New.
Da: Revaluation Books, Exeter, Regno Unito
EUR 84,54
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 212 pages. 9.00x6.00x9.00 inches. In Stock.
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 78,38
Quantità: 1 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.
PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
EUR 153,70
Quantità: 1 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 164,60
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 182,18
Quantità: 10 disponibili
Aggiungi al carrelloCondizione: New. Presents an examination of contraceptive development in the United States, covering research, funding, regulation, product liability, and the effect of public opinion. This book provides a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public. Num Pages: 212 pages. BIC Classification: KNDP; MBNH4. Category: (P) Professional & Vocational. Dimension: 229 x 152. . . 1990. Revised ed. paperback. . . . .
Condizione: New. Presents an examination of contraceptive development in the United States, covering research, funding, regulation, product liability, and the effect of public opinion. This book provides a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public. Num Pages: 212 pages. BIC Classification: KNDP; MBNH4. Category: (P) Professional & Vocational. Dimension: 229 x 152. . . 1990. Revised ed. paperback. . . . . Books ship from the US and Ireland.
Lingua: Inglese
Editore: National Academies Press, US, 1990
ISBN 10: 0309083524 ISBN 13: 9780309083522
Da: Rarewaves.com UK, London, Regno Unito
EUR 191,61
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: New. There are numerous reasons to hasten the introduction of new and improved contraceptives--from health concerns about the pill to the continuing medical liability crisis. Yet, U.S. organizations are far from taking a leadership position in funding, researching, and introducing new contraceptives--in fact, the United States lags behind Europe and even some developing countries in this field. Why is research and development of contraceptives stagnating? What must the nation do to energize this critical arena? This book presents an overall examination of contraceptive development in the United States--covering research, funding, regulation, product liability, and the effect of public opinion. The distinguished authoring committee presents a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public.The highly readable and well-organized volume will quickly become basic reading for legislators, government agencies, the pharmaceutical industry, private organizations, legal professionals, and researchers--everyone concerned about family planning, reproductive health, and the impact of the liability and regulatory systems on scientific innovations.